-

Cresco Labs Announces Three New Sunnyside Dispensaries in Florida

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), a vertically integrated multistate operator and the No. 1 U.S. wholesaler of branded cannabis products, today announced the expansion of its Sunnyside retail brand in Florida with three new dispensaries in Cape Coral, Tampa and Panama City Beach, Florida. These additional stores bring Cresco’s store network to 19 locations in Florida and 53 total in the U.S.

“We are thrilled to bring Cresco Labs’ portfolio of leading cannabis brands to patients in Cape Coral, Tampa and Panama City Beach,” said Charlie Bachtell, Co-Founder and CEO of Cresco Labs. “When patients have the opportunity to visit our stores and try our category leaders such as High Supply flower and vapes and Sunnyside Chews edibles, they understand why we are the No. 1 wholesaler of branded cannabis products in the U.S. per BDSA. With nearly 750,000 qualified patients, over $2 billion in market revenue (per BDSA) and adult-use still on the horizon, Florida remains an attractive growth opportunity. We have several additional locations planned for the fourth quarter of 2022 and early 2023, which, combined with Columbia Care’s retail footprint, will help us reach our goal of becoming one of the leading operators in the state.”

Sunnyside Cape Coral is the Company’s first dispensary in North Lee County. It resides near a Walmart Supercenter and Publix and is a half mile from city thoroughfare Veterans Parkway.

Sunnyside Tampa is in the heart of the city’s primary retail corridor across from Walmart and Best Buy and just five minutes to Raymond James Stadium. It also is accessibly located just off the I-275.

Sunnyside Panama City Beach will be opening in a few weeks located a few blocks from scenic Hwy 30A, which is easily accessible to locals, commuters and guests of numerous beachside resorts.

All dispensary store hours are 9am – 8pm, Monday through Saturday, and 9am – 6pm Sunday. For more information about Sunnyside, promotions and to place online orders, visit www.sunnyside.shop.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Cresco Labs Inc.

CNSX:CL

Release Summary
Cresco Labs Announces Three New Sunnyside Dispensaries in Florida
Release Versions

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

More News From Cresco Labs Inc.

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

CHICAGO--(BUSINESS WIRE)--Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement...

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide...

Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Tamarac, located at 6001 N University Drive in Tamarac, Fla. It is the Company’s 31st dispensary in Florida and 72nd nationwide. “Florida is the largest medical market in the country, and opening Sunnyside Tamarac reinforces our long-term commitment to serving patients across the state,” said Charlie Bachtell, CEO of Cresco Labs. “We’re...
Back to Newsroom